netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 5 of 5


Details
UPD Lanadelumab (Takhzyro) PUBLISHED
14/01/2020 08:34:18
(MargaretS )
UPD Lanadelumab (Takhzyro) Updated indication info
10/01/2020 10:36:56
(Hardip )
UPD Lanadelumab (Takhzyro) IMPLEMENTATION DATE NOT DUE
06/01/2020 14:33:58
(MargaretS )
LDL Link Added : NICE TA606: Lanadelumab for preventing recurrent attacks of hereditary angioedema : https://www.nice.org.uk/guidance/ta606
06/12/2019 08:32:42
(DenisK )
ADD Lanadelumab (Takhzyro®) add
06/12/2019 08:31:43
(DenisK )

 

 

netFormulary